AURO-LEVETIRACETAM 250 levetiracetam 250 mg tablets Bottle

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Osta kohe

Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
28-11-2017

Toimeaine:

levetiracetam, Quantity: 250 mg

Saadav alates:

Strides Pharma Science Pty Ltd

INN (Rahvusvaheline Nimetus):

Levetiracetam

Ravimvorm:

Tablet, film coated

Koostis:

Excipient Ingredients: purified talc; magnesium stearate; povidone; colloidal anhydrous silica; maize starch; titanium dioxide; hypromellose; indigo carmine; macrogol 4000

Manustamisviis:

Oral

Ühikuid pakis:

60, 30

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

It is indicated for:,? use in epileptic patients aged 4 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation,,? monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy.,? add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy (JME),and,? add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (IGE).

Toote kokkuvõte:

Visual Identification: Blue, oval shaped, biconvex film-coated tablets debossed with a deep break line separating 'E' and '10' on one side and plain on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2011-12-23